Article Details
Retrieved on: 2018-05-04 06:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>BlackRock Inc</b>. grew its holdings in Akcea Therapeutics (NASDAQ:AKCA) by 117.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,826,152 shares of the company's stock after purchasing an additional ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here